TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB March 19, 1999